A Gene‐Switch Platform Interfacing with Reactive Oxygen Species Enables Transcription Fine‐Tuning by Soluble and Volatile Pharmacologics and Food Additives
Open Access
- 25 March 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (20) , e2306333
Abstract
Synthetic biology aims to engineer transgene switches for precise therapeutic protein control in cell‐based gene therapies. However, off‐the‐shelf trigger‐inducible gene circuits are usually switched on by single or structurally similar molecules. This study presents a mammalian gene‐switch platform that controls therapeutic gene expression by a wide range of molecules generating low, non‐toxic levels of reactive oxygen species (ROS). In this system, KEAP1 (Kelch‐like ECH‐associated protein 1) serves as ROS sensor, regulating the translocation of NRF2 (nuclear factor erythroid 2‐related factor 2) to the nucleus, where NRF2 binds to antioxidant response elements (ARE) to activate the expression of a gene of interest. It is found that a promoter containing eight‐tandem ARE repeats is highly sensitive to the low ROS levels generated by the soluble and volatile molecules, which include food preservatives, food additives, pharmaceuticals, and signal transduction inducers. In a proof‐of‐concept study, it is shown that many of these compounds can independently trigger microencapsulated engineered cells to produce sufficient insulin to restore normoglycemia in experimental type‐1 diabetic mice. It is believed that this system greatly extends the variety of small‐molecule inducers available to drive therapeutic gene switches.Keywords
Funding Information
- European Research Council (ElectroGene(785800))
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung
This publication has 44 references indexed in Scilit:
- Synthetic Gene Circuits for Regulation of Next‐Generation Cell‐Based TherapeuticsAdvanced Science, 2023
- Regulation of Transgene Expression by the Natural Sweetener XyloseAdvanced Science, 2022
- Engineering a Rapid Insulin Release System Controlled By Oral Drug AdministrationAdvanced Science, 2022
- Artemisinin conferred ERK mediated neuroprotection to PC12 cells and cortical neurons exposed to sodium nitroprusside-induced oxidative insultFree Radical Biology and Medicine, 2016
- The Keap1–Nrf2–ARE Pathway As a Potential Preventive and Therapeutic Target: An UpdateMedicinal Research Reviews, 2016
- Dimethyl Fumarate for Treatment of Multiple Sclerosis: Mechanism of Action, Effectiveness, and Side EffectsCurrent Neurology and Neuroscience Reports, 2013
- Discovery of small molecule cancer drugs: Successes, challenges and opportunitiesMolecular Oncology, 2012
- The cytoprotective role of the Keap1–Nrf2 pathwayArchives of Toxicology, 2011
- A Tunable Genetic Switch Based on RNAi and Repressor Proteins for Regulating Gene Expression in Mammalian CellsCell, 2007
- Effects of cysteine and diethylmaleate pretreatments on renal function and response to a nephrotoxicantArchives of Toxicology, 1986